Loading...
NASDAQ: PODD
Insulet Corporation
Healthcare · Medical - Devices
●S&P 500 since 2023
Market Cap
$16.21B
52w High
$354.88
52w Low
$216.49
P/E
65.57
Volume
729.09K
Outstanding Shares
70.40M
Company profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
CEOAshley A. McEvoy
SectorHealthcare
IndustryMedical - Devices
Employees5,400
IPO dateMay 15, 2007
Valuation
Forward P/E—
EV/EBITDA34.64
Enterprise value$20.33B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth31.18%
Gross margin71.63%▲2.65%vs FY2024
Operating margin17.5%▲17.33%vs FY2024
ROE16.31%▼52.76%vs FY2024
Analyst consensus
RatingBuy
Target price$357.25▲55.14%
36
Buy
10
Hold
3
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.17
$0.92
Q3FY25
ActualEst.
$1.24
$1.14
Q4FY25
ActualEst.
$1.55
$1.48
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$649.1M
$614.2M
Q3FY25
ActualEst.
$706.3M
$678.41M
Q4FY25
ActualEst.
$783.8M
$728.74M
Q1FY26
Next Est.
—